Helvetica expanded its portfolio of accepted articles and published the first manuscript on 'Synthetic Procedures':
Large-scale synthesis of 4-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid – a key fragment of Single Orexin Receptor Antagonist ACT-539313 – via Cu2O-catalyzed, ligand-free Ullmann-Goldberg Coupling
Gabriel Schäfer, Tony Fleischer
First published: 11 November 2022, DOI: https://doi.org/10.1002/hlca.202200162
«I am sure this will have a positive impact for Helvetica and the entire Swiss chemical society. We feel proud to have contributed the "inaugural manuscript".» Gabriel Schäfer mentioned after the publication. Congratulation!
Dr. Richard J. Smith
Executive Editor, Helvetica Chimica Acta
Phone: +41 44 360 24 31